Healthcare & Life Sciences
Biohaven Pharmaceuticals
United Stateswww.biohavenpharma.com/
Biohaven Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Biohaven Pharmaceuticals
Based in the United States, Biohaven Pharmaceuticals is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Biohaven Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops, and commercializes therapies across neuroscience, immunology, obesity, and oncology, notably offering migraine treatments such as Nurtec ODT and Zavzpret.
Explore Biohaven Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.